(Q46877450)

26 December 2017

title

Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism (English)

1 reference

26 December 2017

1 reference

1 reference

1 reference

1 reference

Merza Z

1

1 reference

26 December 2017

Blumsohn A

2

1 reference

26 December 2017

Mah PM

3

1 reference

26 December 2017

Meads DM

4

1 reference

26 December 2017

McKenna SP

5

1 reference

26 December 2017

Wylie K

6

1 reference

26 December 2017

Eastell R

7

1 reference

26 December 2017

Wu F

8

1 reference

26 December 2017

Ross RJ

9

1 reference

26 December 2017

publication date

22 December 2005

1 reference

26 December 2017

International Journal of Andrology

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 December 2017

volume

29

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

381-391

1 reference

26 December 2017

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Hypogonadotropic hypogonadal men respond less well to androgen substitution treatment than hypergonadotropic hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Treatment of Isolated Hypogonadotropic Hypogonadism Effect on Bone Mineral Density and Bone Turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Blood testosterone threshold for androgen deficiency symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Hypogonadism in elderly men--what to do until the evidence comes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Cross-cultural development of a quality of life measure for men with erection difficulties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00612.X

10.1111/J.1365-2605.2005.00612.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017